Annual Revenue:
$45.56M+$31.47M(+223.37%)Summary
- As of today, NAMS annual revenue is $45.56 million, with the most recent change of +$31.47 million (+223.37%) on December 31, 2024.
- During the last 3 years, NAMS annual revenue has risen by +$45.56 million (+100.00%).
- NAMS annual revenue is now -55.63% below its all-time high of $102.69 million, reached on December 31, 2022.
Performance
NAMS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$348.00K-$18.80M(-98.18%)Summary
- As of today, NAMS quarterly revenue is $348.00 thousand, with the most recent change of -$18.80 million (-98.18%) on September 30, 2025.
- Over the past year, NAMS quarterly revenue has dropped by -$28.76 million (-98.80%).
- NAMS quarterly revenue is now -98.80% below its all-time high of $29.11 million, reached on September 30, 2024.
Performance
NAMS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$35.24M-$28.76M(-44.94%)Summary
- As of today, NAMS TTM revenue is $35.24 million, with the most recent change of -$28.76 million (-44.94%) on September 30, 2025.
- Over the past year, NAMS TTM revenue has increased by +$2.45 million (+7.48%).
- NAMS TTM revenue is now -44.94% below its all-time high of $64.01 million, reached on June 30, 2025.
Performance
NAMS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NAMS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +223.4% | -98.8% | +7.5% |
| 3Y3 Years | +100.0% | +100.0% | +100.0% |
| 5Y5 Years | +100.0% | +100.0% | +100.0% |
NAMS Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -55.6% | >+9999.0% | -98.8% | >+9999.0% | -44.9% | >+9999.0% |
| 5Y | 5-Year | -55.6% | >+9999.0% | -98.8% | >+9999.0% | -44.9% | >+9999.0% |
| All-Time | All-Time | -55.6% | >+9999.0% | -98.8% | >+9999.0% | -44.9% | >+9999.0% |
NAMS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $348.00K(-98.2%) | $35.24M(-44.9%) |
| Jun 2025 | - | $19.14M(+542.9%) | $64.01M(+35.8%) |
| Mar 2025 | - | $2.98M(-76.7%) | $47.14M(+3.5%) |
| Dec 2024 | $45.56M(+223.4%) | $12.77M(-56.1%) | $45.56M(+38.9%) |
| Sep 2024 | - | $29.11M(+1177.4%) | $32.79M(+791.1%) |
| Jun 2024 | - | $2.28M(+62.7%) | $3.68M(+162.7%) |
| Mar 2024 | - | $1.40M(-83.8%) | $1.40M(-83.8%) |
| Dec 2023 | $14.09M(-86.3%) | - | - |
| Mar 2023 | - | $8.63M | $8.63M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $102.69M(>+9900.0%) | - | - |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00 | $0.00 | $0.00 |
FAQ
- What is NewAmsterdam Pharma Company N.V. annual revenue?
- What is the all-time high annual revenue for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. annual revenue year-on-year change?
- What is NewAmsterdam Pharma Company N.V. quarterly revenue?
- What is the all-time high quarterly revenue for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. quarterly revenue year-on-year change?
- What is NewAmsterdam Pharma Company N.V. TTM revenue?
- What is the all-time high TTM revenue for NewAmsterdam Pharma Company N.V.?
- What is NewAmsterdam Pharma Company N.V. TTM revenue year-on-year change?
What is NewAmsterdam Pharma Company N.V. annual revenue?
The current annual revenue of NAMS is $45.56M
What is the all-time high annual revenue for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high annual revenue is $102.69M
What is NewAmsterdam Pharma Company N.V. annual revenue year-on-year change?
Over the past year, NAMS annual revenue has changed by +$31.47M (+223.37%)
What is NewAmsterdam Pharma Company N.V. quarterly revenue?
The current quarterly revenue of NAMS is $348.00K
What is the all-time high quarterly revenue for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high quarterly revenue is $29.11M
What is NewAmsterdam Pharma Company N.V. quarterly revenue year-on-year change?
Over the past year, NAMS quarterly revenue has changed by -$28.76M (-98.80%)
What is NewAmsterdam Pharma Company N.V. TTM revenue?
The current TTM revenue of NAMS is $35.24M
What is the all-time high TTM revenue for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high TTM revenue is $64.01M
What is NewAmsterdam Pharma Company N.V. TTM revenue year-on-year change?
Over the past year, NAMS TTM revenue has changed by +$2.45M (+7.48%)